Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M

Regeneron Pharmaceuticals reports 2018 executive compensation

By ExecPay News

Published: April 26, 2019

Regeneron Pharmaceuticals reported fiscal year 2018 executive compensation information on April 26, 2019.
In 2018, five executives at Regeneron Pharmaceuticals received on average a compensation package of $16M, a 2% decrease compared to previous year.
Average pay of disclosed executives at Regeneron Pharmaceuticals
Leonard S. Schleifer, Chief Executive Officer, received $27M in total, which is about the same as previous year. 80% of Schleifer's compensation, or $21M, was in option awards. Schleifer also received $3M in non-equity incentive plan, $1.3M in salary, as well as $896K in other compensation.
George D. Yancopoulos, Chief Scientific Officer, received a compensation package of $25M, which is about the same as previous year. 84% of the compensation package, or $21M, was in option awards.
Marion McCourt, Senior Vice President, Commercial, earned $10M in 2018.
Robert E. Landry, Chief Financial Officer, received $9.4M in 2018, which increases by 95% compared to 2017.
Daniel Van Plew, Executive Vice President and General Manager, Industrial Operations and Product Supply, earned $9M in 2018, which is about the same as previous year.

Related executives

Leonard Schleifer

Regeneron Pharmaceuticals

Chief Executive Officer

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

Daniel Van Plew

Regeneron Pharmaceuticals

Executive Vice President and General Manager, Industrial Operations and Product Supply

Marion McCourt

Regeneron Pharmaceuticals

Senior Vice President, Commercial

You may also like

Source: SEC filing on April 26, 2019.

Promoted Videos

YouTube icon